GAS5 is known to function as a tumor suppressor in several types of cancer. It is often found to be downregulated in cancerous tissues compared to normal tissues. This downregulation is associated with poor prognosis and increased tumorigenesis, suggesting its potential role as a biomarker and therapeutic target.